高雄榮總肺高壓專業治療中心 | 合法藥品大搜索

臨床使用: 目前Ambrisentan於2009 年12 月1日核准上市。健保核准用在運動能力差(WHO 功能分級III及IV)不明原因 ... Read More

英文商品名 : Volibris 中文商品名 : 肺博舒 主成分 : Ambrisentan 劑型劑量 : 膜衣錠，5 mg/tablet，10 mg/tablet。 適應症 : Ambrisentan適用於治療原發性肺動脈高 ... Read More

Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of ... Read More

2020年11月20日 — Ambrisentan is an oral medication classified as an endothelin receptor antagonist (ERA) which is approved for the treatment of pulmonary ... Read More

Ambrisentan Mylan is a medicine that is used alone or combined with other medicines to treat adults with pulmonary arterial hypertension (PAH). Read More

Ambrisentan is used to treat high blood pressure in the lungs (pulmonary arterial hypertension). This condition is thought to be caused by increased levels of a ... Read More

Ambrisentan is an orally active selective type A endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension. It is approved in ... Read More

Ambrisentan is an orally active selective type A endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension. It is approved in ... Read More

由 N Galiè 著作 · 2008 · 被引用 1065 次 — Ambrisentan is a nonsulfonamide, propanoic acid–based, A-selective endothelin receptor antagonist with a bioavailability and half-life that allow once-daily dosing​ ... Read More